medicare glp-1 New Bridge Program Launching July 1, 2026 Medicare obesity drug GLP-1 coverage

"Although excess body weight is the major predisposing factor for sleep apnea, many cases of sleep apnea are related to other factors such as the structure of the jaw and upper airway," the group said in a statement on Saturday

Rare Disease Day Webinar: Voices that move systems Access the webinar replay offering actionable, cross-geography insights on how patient and caregiver voices can improve diagnosis, engagement, and outcomes

While both medications may cause appetite suppression and cardiovascular effects , their combination necessitates careful monitoring of potential side effects, including gastrointestinal symptoms and risks of hypoglycemia

When given orally, semaglutide is dosed differently as absorption and delivery are different from injectable semaglutide (more on that below)